Franklin Resources
GYRE icon

Franklin Resources’s Gyre Therapeutics GYRE Stock Holding History

Franklin Resources’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-779
Closed -$1.71M – 1596
2015
Q2 		$1.71M Hold
779
– – ﹤0.01% 1338
2015
Q1 		$1.82M Hold
779
– – ﹤0.01% 1328
2014
Q4 		$1.61M Hold
779
– – ﹤0.01% 1333
2014
Q3 		$1.55M Sell
779
-2,667
-77% -$6.59M ﹤0.01% 1346
2014
Q2 		$12.2M Buy
3,446
+444
+15% +$1.45M 0.01% 1015
2014
Q1 		$11.2M Buy
3,002
+1,408
+88% +$5.21M 0.01% 1008
2013
Q4 		$5.21M Buy
1,594
+102
+7% +$402K ﹤0.01% 1128
2013
Q3 		$6.24M Buy
1,492
+193
+15% +$777K ﹤0.01% 1078
2013
Q2 		$4.37M Buy
+1,299
New +$4.94M ﹤0.01% 1105

Other funds holding GYRE

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Franklin Resources's GYRE Position: Q3 2015 in Review

Franklin Resources sold out of Gyre Therapeutics (GYRE) in Q3 2015, closing a stake of 779 shares — an estimated $1.71M sold.

Franklin Resources first reported a position in GYRE in Q2 2013 and held it in 9 quarters. The position peaked at $12.2M in Q2 2014. 39 funds tracked by Wall St. Rank hold GYRE as of Q3 2015.

  • Franklin Resources reported no remaining Gyre Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Franklin Resources sold 779 Gyre Therapeutics shares in Q3 2015, an estimated $1.71M.
  • Franklin Resources first reported a position in Gyre Therapeutics in Q2 2013 and held it in 9 quarters.
  • Franklin Resources's Gyre Therapeutics position peaked at $12.2M in Q2 2014.
  • 39 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2015.

Based on Franklin Resources's 13F filing for Q3 2015, filed 10 Nov 2015.